Embracing Imperfection for Impact: The Bold Move to Measure Medical Impact
In this webinar we discuss the best practices and hurdles to implement tangible medical affairs impact measurement.
In this webinar we discuss the best practices and hurdles to implement tangible medical affairs impact measurement.
In this On-demand webinar, we discuss key considerations for driving our function forward on impact, initiating conversations on impact, and practical considerations for improving the evaluation of impact.
In this forum, we will share traditional medical insights with the innovative world of omnichannel strategies.
Medical Affairs is uniquely positioned as the only department capable of impacting the Enterprise Commercialization Process (ECP) at every stage, from the initial product concept through the entire commercialization effort.
This article explores how Sumitomo Pharma America (SMPA) leveraged H1’s advanced data capabilities to integrate diverse insights, enhance field medical strategies, and foster cross-functional collaboration across therapeutic areas.
This article based on the Oct 3, 2024 Insights FAWG Forum explores the potential for artificial intelligence (AI) to transform Medical Affairs, focusing on medical insights.
Take advantage of alternative impact metrics that better reflect the multidimensional nature of today’s research dissemination and consumption.
In this webinar, we will share new data showing that while medical affairs is increasing in importance, it is still struggling to reach a consensus around medical impact metrics. However, measuring medical impact is no longer a choice; it’s a necessity for medical to communicate its value as a business function and better demonstrate its contributions to successful patient outcomes.
